IPSC Depository

IPSC Depository is a wholly-owned subsidiary of CytoMed Therapeutics Limited. The company mainly focuses on storing clients' cells for future use. CycloMed Therapeutics is a deep technology company established in 2018, dedicated to transforming its patented technologies into "off-the-shelf" immunotherapeutic agents for various cancers. CycloMed also focuses on producing induced pluripotent stem cells (iPSC) and utilizing proprietary technology to develop them into cellular therapies for clients. CycloMed has built its state-of-the-art GMP facility to support cell therapy and cell banking activities.